Invention Grant
US08268321B2 Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same
有权
能够进行经粘膜和透皮给药的抗原药物，以及诱导粘膜免疫和粘膜疫苗的方法和使用其的DDS
- Patent Title: Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same
- Patent Title (中): 能够进行经粘膜和透皮给药的抗原药物，以及诱导粘膜免疫和粘膜疫苗的方法和使用其的DDS
-
Application No.: US11547650Application Date: 2005-03-22
-
Publication No.: US08268321B2Publication Date: 2012-09-18
- Inventor: Hiroshi Kido , Dai Mizuno
- Applicant: Hiroshi Kido , Dai Mizuno
- Applicant Address: JP Tokushima
- Assignee: The University of Tokushima
- Current Assignee: The University of Tokushima
- Current Assignee Address: JP Tokushima
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2004-111249 20040405; JP2004-125036 20040421
- International Application: PCT/JP2005/005659 WO 20050322
- International Announcement: WO2005/097182 WO 20051020
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/38 ; A61K39/12 ; A61K39/145
Abstract:
Disclosed are an antigen-drug vehicle (AD vehicle) exerting a function of inducing the preferential and selective production of an antigen-specific secretory IgA antibody, local immunity or mucosal immunity; a method of inducing mucosal immunity, a mucosal vaccine and a preventive or a remedy for allergy using the above AD vehicle; and a transmucosal or transdermal DDS using the above vehicle.
Public/Granted literature
Information query
